Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Cethexonium→

Cethexonium Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
6810-42-0
Molecular formula
C24H50NO+
Molecular weight
368.7 g/mol
Drug class
Ganglionic nicotinic acetylcholine receptor antagonisthistorical antihypertensive
Mechanism of action
Blocks neuronal nicotinic acetylcholine receptors in autonomic ganglia, reducing sympathetic and parasympathetic transmission and producing marked autonomic blockade.
Indications / reported uses
  • Historical use for severe hypertension before modern antihypertensive agents became available; not a routine contemporary treatment and current medicinal authorisation is not established

Sources: NLM MeSH — Cethexonium · PubMed — Cethexonium ganglionic blocker · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Cethexonium Environmental Risk Assessment (ERA) (the Cethexonium ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.